首页 | 本学科首页   官方微博 | 高级检索  
检索        

GP方案与NP方案治疗晚期非小细胞肺癌对比观察
引用本文:刘少兵,盘玉飞.GP方案与NP方案治疗晚期非小细胞肺癌对比观察[J].中国肿瘤临床与康复,2010(1):27-29.
作者姓名:刘少兵  盘玉飞
作者单位:广西区第二人民医院肿瘤一区;
摘    要:目的比较GP方案与NP方案治疗晚期非小细胞肺癌的疗效和毒性反应。方法56例晚期非小细胞肺癌随机分为两组,GP组29例,吉西他滨1.0~1.2g/m^2,第1、第8天,静脉滴注;顺铂25mg/m^2,第1~3天,静脉滴注。NP组27例,长春瑞滨25mg/m^2,第1、第8天,静脉推注;顺铂25mg/m^2,第1~3天,静脉滴注,21d为1个周期,治疗2个周期以上评定疗效,同时予水化、利尿等处理。结果GP组有效率44.8%,NP组有效率40.7%,两组差异无显著性(P〉0.05)。骨髓抑制为两组的主要毒性反应,其中NP组白细胞下降发生率高于GP组(85.2%对51.7%,P〈0.05),GP组血小板下降发生率高于NP组(82.8%对22.2%,P〈0.05),NP组静脉炎反应较GP组重(29.6%对6.9%,P〈0.05),两组比较差异有显著性。结论GP方案与NP方案治疗晚期非小细胞肺癌疗效显著,毒性反应各异,但可耐受。

关 键 词:肺肿瘤/化学疗法  吉西他滨  长春瑞滨  顺铂

The comparison between GP and NP regimens for treatment of advanced non-small cell lung cancer
LIU Shao-bing,PAN Yu-fei.The comparison between GP and NP regimens for treatment of advanced non-small cell lung cancer[J].Chinese Journal of Clinical Oncology and Rehabilitation,2010(1):27-29.
Authors:LIU Shao-bing  PAN Yu-fei
Institution:LIU Shao-bing,PAN Yu-fei(Department of Medical Oncology,Guangxi Number 2 People Hospital,Guilin,541002 China)
Abstract:Objective To compare the efficacy and toxicity between GP(gemcitabine +cisplatin) regimen and NP(vinorelbine + cisplatin) regimen in the treatment of advanced non-small cell lung cancer(NSCLC).Methods Fifty-six cases of advanced NSCLC were enrolled:29 cases were treated with GP regimen(GEM 1.0-1.2 g/m2,ivgtt d1 and d8,DDP 25 mg/m2,ivgtt d1-3),27 cases were treated with NP regimen(NVB 25 mg/m2,iv d1 and d8,DDP 25 mg/m2,ivgtt d1-3).The treatment in two groups was repeated every three weeks and the efficacy wa...
Keywords:Lung neoplasms/chemotherapy  Gemcitabine  Vinorelbine  Cisplatin  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号